アブカムでは最適な動作のために Google Chrome など最新ブラウザでの閲覧を推奨します。
Professor Roger Barker, Professor of Clinical Neuroscience, University of Cambridge.
Professor Barker explains where we are with research in 2019 and how our understanding of the disease has progressed, before exploring emerging trends and therapies.
Emerging trends discussed include the role of alpha-synuclein, drug repurposing, providing ‘fertilizer’ to dopamine cells such as in GDNF trials, stem cell-derived dopamine replacement, and gene therapy.
>> In collaboration with The MJFF, we developed a range of RabMAb® products to bring you the tools you need for Parkinson’s disease research. Please see here to find out more about these products and our partnership.
15:55 minutes - Professor Roger Barker, Professor of Clinical Neuroscience, University of Cambridge.
To help you get ahead in your Parkinson’s research, we’ve compiled the best neuronal markers to use in conjunction with our disease-specific antibodies.
Proliferating cell marker
Schwann cell/Radial glia/Astrocyte
Serotonergic neuron/Dopaminergic neuron